A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia (AML) by helping doctors identify if they might relapse up to three ...

Acute myeloid leukemia (AML) is an aggressive blood cell cancer that is currently not well treated. (1) Existing therapies include classical chemotherapeutic agents, FLT3 kinase inhibitors, and, for ...

Menin inhibitors are a particularly exciting opportunity for the subset of young leukemia patients with KMT2A, NMP1, and NUP98 alterations. Kolb noted that these alterations occur in about 40 percent ...

"I'm a workaholic - in a healthy way" - Atomic chief executive Jo Haanstra. The software of a firm run by one of New Zealand’s top former netballers plays a key role in the fight against scams ...

Easy as ABC: Managing Toxicities of Antibody-Drug Conjugates, Bispecific Antibodies, and CAR T-Cell Therapies The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia ...

Which Is the Best Tyrosine Kinase Inhibitor for Newly Diagnosed Chronic Myelogenous Leukemia? Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with ...

What are the symptoms of chronic myeloid leukemia (CML)? Many people don’t have any symptoms when they're diagnosed with CML. It's often found when a person has blood tests done for another reason and ...

This time, it’s not just her role—it’s her powerful real-life story. Garcia recently opened up about surviving Acute Myelogenous Leukemia. Her journey is nothing short of miraculous. Let’s dive into ...

The European Group for Blood and Marrow Transplantation performed a registry-based retrospective comparison of the outcomes of patients with AML aged ... 4 acute GVHD and leukemia-free survival ...

Changes to anti-money laundering rules announced by the Government last year are welcome but will not, on their own, do enough to address inconsistencies in the way businesses are assessed for their ...